The Digital Platform and Its Emerging Role in Decentralized Clinical Trials
Journal of Medical Internet Research · 2024-09-03 · 26 · e47882
DOI: 10.2196/47882 ↗At a glance
Journal article in Journal of Medical Internet Research, published online on 2024-09-03. Written by Rachel R Copland and 8 co-authors. Institution: MEMO Research, School of Medicine, University of Dundee, Dundee, United Kingdom. Major MEDLINE topics: Clinical Trials as Topic. Cited 16 times so far (Crossref); 124 references. The full text is freely available in PubMed Central.
Abstract (original language)
Decentralized clinical trials (DCTs) are becoming increasingly popular. Digital clinical trial platforms are software environments where users complete designated clinical trial tasks, providing investigators and trial participants with efficient tools to support trial activities and streamline trial processes. In particular, digital platforms with a modular architecture lend themselves to DCTs, where individual trial activities can correspond to specific platform modules. While design features can allow users to customize their platform experience, the real strengths of digital platforms for DCTs are enabling centralized data capture and remote monitoring of trial participants and in using digital technologies to streamline workflows and improve trial management. When selecting a platform for use in a DCT, sponsors and investigators must consider the specific trial requirements. All digital platforms are limited in their functionality and technical capabilities. Integrating additional functional modules into a central platform may solve these challenges, but few commercial platforms are open to integrating third-party components. The lack of common data standardization protocols for clinical trials will likely limit the development of one-size-fits-all digital platforms for DCTs. This viewpoint summarizes the current role of digital platforms in supporting decentralized trial activities, including a discussion of the potential benefits and challenges of digital platforms for investigators and participants. We will highlight the role of the digital platform in the development of DCTs and emphasize where existing technology is functionally limiting. Finally, we will discuss the concept of the ideal fully integrated and unified DCT and the obstacles developers must address before it can be realized.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- MEMO Research, School of Medicine, University of Dundee, Dundee, United Kingdom.
- eHealth, FH Joanneum, Graz, Austria.
- Information Technologies Institute, Centre for Research & Technology Hellas, Thessaloniki, Greece.
ORCID profiles: Rachel R Copland, Sten Hanke, Amy Rogers, Lampros Mpaltadoros, Ioulietta Lazarou, Alexandra Zeltsi, Spiros Nikolopoulos, Thomas M MacDonald, Isla S Mackenzie
Cite
APA
Copland, R. R., Hanke, S., Rogers, A., Mpaltadoros, L., Lazarou, I., Zeltsi, A., Nikolopoulos, S., MacDonald, T. M., & Mackenzie, I. S. (2024). The Digital Platform and Its Emerging Role in Decentralized Clinical Trials. Journal of Medical Internet Research, 26, e47882. https://doi.org/10.2196/47882
Vancouver
Copland RR, Hanke S, Rogers A, Mpaltadoros L, Lazarou I, Zeltsi A, et al. The Digital Platform and Its Emerging Role in Decentralized Clinical Trials. Journal of Medical Internet Research. 2024;26:e47882. doi:10.2196/47882
BibTeX
@article{Copland2024,
author = {Copland, Rachel R and Hanke, Sten and Rogers, Amy and Mpaltadoros, Lampros and Lazarou, Ioulietta and Zeltsi, Alexandra and Nikolopoulos, Spiros and MacDonald, Thomas M and Mackenzie, Isla S},
title = {The Digital Platform and Its Emerging Role in Decentralized Clinical Trials},
journal = {Journal of Medical Internet Research},
year = {2024},
volume = {26},
pages = {e47882},
doi = {10.2196/47882}
}
EUVIMED